Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Melanoma 1486Lymphoma, T-Cell, Cutaneous 313Skin Neoplasms 268Keratosis, Actinic 249Mycosis Fungoides 224Sezary Syndrome 216Lymphoma, Non-Hodgkin 206Leukemia, Lymphocytic, Chronic, B-Cell 200Lymphoma, Large B-Cell, Diffuse 198Lymphoma, Follicular 196Neoplasms 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, B-Cell, Marginal Zone 192Lymphoma, Mantle-Cell 191Hodgkin Disease 191Carcinoma, Basal Cell 190Breast Neoplasms 185Burkitt Lymphoma 184Lymphoma 182Lymphoma, Large-Cell, Immunoblastic 177Carcinoma, Non-Small-Cell Lung 150Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 140Lymphoma, Large-Cell, Anaplastic 137Multiple Myeloma 133Carcinoma, Renal Cell 128Immunoblastic Lymphadenopathy 126Uveal Melanoma 125Neoplasm Metastasis 120Leukemia, Myeloid, Acute 113Waldenstrom Macroglobulinemia 103

Interventions

pembrolizumab 1omega-N-Methylarginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × DNA Repair-Deficiency Disorders × Dermatologic × Clear all
NCT03236935 2026-04-09

Phase Ib of L-NMMA and Pembrolizumab

The Methodist Hospital Research Institute

Phase 1 Completed
12 enrolled 15 charts
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡